Digital health, diagnostics and medical devices, and the signals that matter for adoption, reimbursement and outcomes.
Page 8 of 9
Jan 30, 2026As digital care continues to transform healthcare delivery, Maven Clinic’s research institute represents a strategic effort to assess and amplify the impact of such innovations. This analytic post explores the institute's mission, expected contributions, and potential implications for women’s and family health.
Jan 30, 2026The dispute between Epic Systems and Health Gorilla goes beyond a single lawsuit, reflecting broader tensions within healthcare’s evolving digital landscape. This article examines the implications of this case for medical record control, data sharing protocols, and regulatory frameworks in healthcare IT.
Jan 29, 2026NOCD’s strategic move to create a parent brand, Noto, marks a significant expansion of its virtual mental health services. With the acquisition of Rebound Health, it aims to address complex conditions like PTSD alongside OCD, reflecting broader trends in digital mental health care innovation.
Jan 27, 2026Early cancer detection remains a critical challenge in oncology, with significant implications for patient outcomes and healthcare costs. Endeavor Health's investigation into blood-based multi-cancer detection tests represents a pivotal step towards wider clinical adoption of these emerging technologies.
Jan 26, 2026In a heartfelt gathering, health care workers came together in Minneapolis to pay tribute to nurse Alex Pretti. The vigil highlighted the strong bonds within the medical community and underscored the profound impact healthcare professionals have on their colleagues and patients alike.
Jan 25, 2026The expansion of AI leaders OpenAI and Anthropic into healthcare marks a pivotal shift. AI chatbots are emerging as frontline tools in patient engagement, redefining the patient-provider dynamic and challenging existing health technology frameworks. This blog explores these changes and their broad implications for the healthcare industry.
Jan 21, 2026Aidoc’s newly cleared AI tool represents a promising advancement in radiological diagnostics by enabling the detection of multiple conditions simultaneously from computed tomography scans. This innovation could streamline diagnosis, improve patient outcomes, and reduce diagnostic errors in clinical settings.
Jan 21, 2026This groundbreaking in-ear EEG system promises to transform monitoring and care for neurological conditions such as epilepsy, Alzheimer's disease, and sleep disorders by enabling brain activity capture in everyday environments, which traditional scalp EEG systems often fail to achieve.
Jan 18, 2026Allergy diagnosis often faces challenges due to incomplete histories and insufficient testing. New approaches focus on capturing detailed symptomatology and applying thorough testing to close this gap, streamline resource use, and enhance safety.
Jan 16, 2026Noninvasive diagnostic devices for liver conditions are gaining prominence due to their ability to provide clinical insights without the need for invasive procedures. This guide explores how these technologies work and profiles leading organizations developing these solutions.
Jan 14, 2026In early 2026, Fullscript launched a partnership with ŌURA to incorporate biometric data from the ŌURA Ring into clinical workflows. This integration aims to enhance patient monitoring and support more informed healthcare decision-making using real-time wearable technology data.
Jan 13, 2026Recent developments in perfusion technologies have expanded the possibilities for organ transplantation, turning what was once a field constrained by scarcity into one characterized by growing opportunity and improved outcomes. By oxygenating and nourishing organs outside the body, these technologies allow for longer preservation and better clinical decision-making.
Machine learning, predictive models and computational biology: how AI is changing discovery workflows and probability of success.
Drug development, clinical trials and industry dynamics. What changes timelines, risk and competitive positioning.
Gene therapy, CRISPR, synthetic biology and emerging platforms. Separating what is real from what is hype, and what actually translates.
Where capital is flowing and why the tape moves, across funding rounds, M&A, IPOs and market analysis.
FDA actions, approvals, policy shifts and compliance: how the rules change timelines and probability.